Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than many expect.

  • Amgen focuses on specialized biological medicines, particularly in oncology and rare diseases.
  • Pfizer operates globally with a vast distribution network and pharmacy chains.
  • Amgen shows higher revenue growth and lower debt-to-equity ratio compared to Pfizer.

More from Thursday 5 November →